A Study to Investigate the Safety, Tolerability, and Pharmacodynamics of JNJ-54175446 in Participants With Major Depressive Disorder
Clinical trial NCT02902601 · COMPLETED
Trial details
- NCT number
- NCT02902601
- Sponsor
- Janssen Research & Development, LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-10-17
- Primary completion
- 2017-06-02
- Enrollment
- 70
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.